Primary cutaneous Cryptococcosis during therapy with methotrexate and adalimumab

Wilson, M.L.; Sewell, L.D.; Mowad, C.M.

Journal of Drugs in Dermatology Jdd 7(1): 53-54

2008


ISSN/ISBN: 1545-9616
PMID: 18246698
Document Number: 14335
Primary cutaneous infection with Cryptococcus neoformans is uncommon, but can occur following an inoculation injury to the skin. Tumor necrosis factor-alpha (TNF-alpha) is important in the immune response to Cryptococcus, and patients taking inhibitors of TNF-alpha may have increased susceptibility to cryptococcal infection. We report a case of primary cutaneous cryptococcosis in a patient taking adalimumab, methotrexate, and hydroxychloroquine for rheumatoid arthritis.

Document emailed within 1 workday
Secure & encrypted payments

Primary cutaneous Cryptococcosis during therapy with methotrexate and adalimumab